Assessing accuracy and precision of developed equations in prediction of blood lithium levels in psychiatric patients in Khon Kaen Rajanagarindra Psychiatric Hospital

Main Article Content

Phensiri Sukon

Abstract

Introduction: Lithium is commonly used as a mood stabilizer in psychiatric patients with mood disorders, especially for the treatment of bipolar disorder. However, lithium has narrow therapeutic index and may cause dangerous toxicity on kidneys. Therefore, optimal dose of lithium is very important to ensure an effective therapy and to prevent its toxicity. In clinical practice, monitoring of blood lithium levels is required. Several methods have been proposed for the dosage determination. One is a priori prediction method that uses patient’s characteristics in mathematic equations for prediction of lithium dose or blood lithium level in the patient. The objective of the present study was to determine the accuracy and precision of 4 developed equations in prediction of blood lithium levels in psychiatric patients in Khon Kaen Rajanagarindra Psychiatric Hospital. Methods: With specific inclusion criteria, data were collected retrospectively from the medical records of patients who received lithium between January 2011 and December 2012. Predicted blood lithium levels were computed from 4 equations: (1) Tearo et al equation, (2) Abou-Auda et al equation, (3) Chiu et al equation, and (4) Huang et al equation. By comparing predicted blood lithium levels from each equation with the actual levels, accuracy of each equation was assessed by computing mean prediction error and percent error and the precision was assessed by computing root mean square error. In addition, correlation coefficients between predicted blood lithium levels and the actual levels were computed for each equation. Sensitivity and specificity tests of each equation were also calculated. Results: Of 620 inpatients who used lithium, only 90 met the inclusion criteria. For accuracy evaluation, the lowest mean prediction error was in Tearo et al equation (median [interquartile range], -0.010 [-0.120 to 0.150] mmol/L; percent error, -1.66% [-21.37% to 27.71%]) compared with Abou-Auda et al equation (-0.685 [-1.0200 to -0.288] mmol/L; -128.23% [-209.54% to -43.24%]), Chiu et al equation (0.110 [-0.040 to 0.275] mmol/L; 21.52% [-6.01% to 68.04%]), and Huang et al equation (-0.175 [-0.300 to -0.045] mmol/L; -33.63% [-47.87% to -13.90%]). For precision evaluation, the lowest root mean square error was in Tearo et al equation (median [interquartile range], 0.141 [0.000 to 0.250]) compared with Abou-Auda et al equation (0.696 [0.312 to 1.100]), Chiu et al equation (0.173 [0.075 to 0.350]), and Huang et al equation (0.173 [0.100 to 0.300]). The greatest Spearman’s rho correlation coefficient between the predicted blood lithium levels and actual blood lithium levels was in Tearo et al equation (=0.666; p-value<0.01) compared with Abou-Auda et al equation (= 0.641; p-value<0.01), Chiu et al equation (= 0.526; p-value<0.01) and Huang et al equation (= 0.438; p-value<0.01). Sensitivity and specificity tests were done to determine the performance of each equation in correctly classifying the patients with their blood lithium levels as being inside the therapeutic range (0.6-1.2 mmol/L). Sensitivity tests of Tearo et al, Abou-Auda et al, Chiu et al, and Huang et al equations were 72%, 8%, 78% and 14%, respectively. Specificity tests of Tearo et al, Abou-Auda et al, Chiu et al, and Huang et al equations were 77%, 90%, 59% and 89%, respectively. Conclusion: Of all 4 equations assessed, Tearo et al equation is the best in accuracy and precision for prediction of blood lithium levels in psychiatric patients in Khon Kaen Rajanagarindra Psychiatric Hospital.

Article Details

Section
Pharmaceutical Practice

References

Abou-Auda HS, Al-Yamani MJ, Abou-Shaaban RR, Khoshhal SI. A new accurate method for predicting lithium clearance and daily dosage requirements in adult psychiatric patients. Bipolar Disord. 2008;10:369-376.

Ahearn EP, Chen P, Hertzberg M, et al., Suicide attempts in veterans with bipolar disorder during treatment with lithium, divalproex, and atypical antipsychotics. J Affect Disord. 2013;145:77-82.

American Psychiatric Association. Practice guideline for the treatment of patients with bipolar disorder (revision). Am J Psychiatry. 2002;159:1-50.

Berk M, Dodd S, Berk L. The management of bipolar disorder in primary care: a review of existing and emerging therapies. Psychiatry Clin Neurosci. 2005;59:229-239.

Bocchetta A, Ardau R, Carta P, et al., Duration of lithium treatment is a risk factor for reduced glomerular function: a cross-sectional study. BMC Med. 2013;11:33. doi:10.1186/1741-7015-11-33

Bowden CL. Efficacy of lithium in mania and maintenance therapy of bipolar disorder. J Clin Psychiatry. 2000;61 Suppl 9:35-40.

Cade JF. Lithium salts in the treatment of psychotic excitement. 1949. Bull World Health Organ. 2000;78:518-520.

Chiu CC, Shen WW, Chen KP, Lu ML. Application of the Cockcroft-Gault method to estimate lithium dosage requirement. Psychiatry Clin Neurosci. 2007;61:269-274.

Collins JC, McFarland BH. Divalproex, lithium and suicide among Medicaid patients with bipolar disorder. J Affect Disord. 2008;107:23-28.

Connolly KR, Thase ME. The clinical management of bipolar disorder: a review of evidence-based guidelines. Prim Care Companion CNS Disord. 2011;13. doi: 10.4088/PCC.10r01097

Goodwin FK, Fireman B, Simon GE, Hunkeler EM, Lee J, Revicki D. Suicide risk in bipolar disorder during treatment with lithium and divalproex. JAMA. 2003;290:1467-1473.

Goodwin GM. Evidence-based guidelines for treating bipolar disorder: recommendations from the British Association for Psychopharmacology. J Psychopharmacol. 2003;17:149-173.

Grandjean EM, Aubry JM. Lithium: updated human knowledge using an evidence-based approach. Part II: Clinical pharmacology and therapeutic monitoring. CNS Drugs. 2009a;23:331-349.

Grandjean EM, Aubry JM. Lithium: updated human knowledge using an evidence-based approach: Part I: Clinical efficacy in bipolar disorder. CNS Drugs. 2009b;23:225-240.

Grunze H, Vieta E, Goodwin GM, et al., The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2012 on the long-term treatment of bipolar disorder. World J Biol Psychiatry. 2013;14:154-219.

Higuchi S, Fukuoka R, Aoyama T, Horioka M. Predicting serum lithium concentration using Bayesian method: a comparison with other methods. J Pharmacobiodyn. 1988;11:158-174.

Huang HC, Chang YL, Lan TH, Chiu HJ, Liu WM, Lee TJ. Prediction of optimal lithium doses for Taiwanese psychiatric patients. J Clin Pharm Ther. 2008;33:115-121.

Maj M. The effect of lithium in bipolar disorder: a review of recent research evidence. Bipolar Disord. 2003;5:180-188.

Malhi GS, Tanious M, Das P, Berk M. The science and practice of lithium therapy. Aust N Z J Psychiatry. 2012;46:192-211.

Pepin SM, Baker DE, Nance KS. Lithium dosage calculation from age, sex, height, weight, amd serum creatinine. Proceedings of the 15th Annual ASHP Midyear Clinical Meeting; Dec. 1980; San Francisco.

Radhakrishnan R, Kanigere M, Menon J, Calvin S, Srinivasan K. Comparison of three a-priori models in the prediction of serum lithium concentration. Indian J Pharmacol. 2012;44:234-237.

Raja M. Lithium and kidney, 60 years later. Curr Drug Saf. 2011;6:291-303.

Royal Australian and New Zealand College of Psychiatrists Clinical Practice Guidelines Team for Bipolar Disorder. Australian and New Zealand clinical practice guidelines for the treatment of bipolar disorder. Aust N Z J Psychiatry. 2004;38:280-305.

Severus WE, Kleindienst N, Seemuller F, Frangou S, Moller HJ, Greil W. What is the optimal serum lithium level in the long-term treatment of bipolar disorder--a review? Bipolar Disord. 2008;10:231-237.

Sheiner LB, Beal SL. Some suggestions for measuring predictive performance. J Pharmacokinet Biopharm. 1981;9:503-512.

Sienaert P, Geeraerts I, Wyckaert S. How to initiate lithium therapy: a systematic review of dose estimation and level prediction methods. J Affect Disord. 2013;146:15-33.

Sproule BA, Bazoon M, Shulman KI, Turksen IB, Naranjo CA. Fuzzy logic pharmacokinetic modeling: application to lithium concentration prediction. Clin Pharmacol Ther. 1997;62:29-40.

Srisurapanont M, Pratoomsri W, Maneeton N. Evaluation of three simple methods for predicting therapeutic lithium doses. Psychiatry Res. 2000;94:83-88.

Terao T, Okuno K, Okuno T, et al., A simpler and more accurate equation to predict daily lithium dose. J Clin Psychopharmacol. 1999;19:336-340.

Wasserman D, Rihmer Z, Rujescu D, et al., The European Psychiatric Association (EPA) guidance on suicide treatment and prevention. Eur Psychiatry. 2012;27:129-141.

Zetin M, Garber D, De Antonio M, et al., Prediction of lithium dose: a mathematical alternative to the test-dose method. J Clin Psychiatry. 1986;47:175-178.